1 Siegel R,NaishadhamD.Cancer statistics,2013[J].CA:A Cancer Journal for Clinicians,2013,63(1):11-30. 2 Allemani C,Matsuda T,Di Carlo V,et al.Global surveillance of trends in cancer survival 2000-14(CONCORD-3):analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]Lancet,2018,391(10125):1023-1075. 3 Romero I.Minirebiew:human ovarian cancer:biology,current management,and paths to personalizing therapy[J].Endocrinology,2012,153(4):1593-1602. 4 Suh DH,Kim JW,Kim K,et al.Major clinical research advances in gynecologic cancer in 2012[J].J Gynecol Oncol,2013,24(1):66-82. 5 Zhou Y,Wang M,Wu J,et al.The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer[J].J Ovarian Res,2015,8:23. 6 Pasquinelli AE.MicroRNAs and their targets:recognition,regulation and an emerging reciprocal relationship[J].Nat Rev Genet,2012,13(4):271-282. 7 Alvarez-Garcia I,Miska EA.MicroRNA functions in animal development and human disease[J].Development,2005,132(21):4653-4662. 8 Xu L,Li H,Su L,et al.MicroRNA-455 inhibits cell proliferation and invasion of epithelial ovarian cancer by directly targeting Notch1[J].Mol Med Rep,2017,16(6):9777-9785. 9 Yang A,Wang X,Yu C,et al.microRNA-494 is a potential prognostic marker and inhibits cellular proliferation,migration and invasion by targeting SIRT1 in epithelial ovarian cancer[J].Oncol Lett,2017,14(3):3177-3184. 10 Guan R,Cai S,Sun M.Upregulation of miR-520b promotes ovarian cancer growth.[J].Oncol Lett,2017,14(3):3155-3161. 11 Wu RL,Ali S,Bandyopadhyay S,et al.Comparative analysis of differentially expressed miRNA and their downstream mRNAs in ovarian cancer and its associated endometriosis[J].J Cancer Sci Ther,2015,7(7):258-265. 12 Zhang S,Zhang JY,Lu LJ,et al.MiR-630 promotes epithelial ovarian cancer proliferation and invasion via targeting KLF6[J].Eur Rev Med Pharmacol Sci,2017,21(20):4542-4547. 13 Hou M,Zuo X,Li C,et al.MiR-29b regulates oxidative stress by targeting SIRT1 in ovarian cancer cells[J].Cell Physiol Biochem,2017,43(5):1767-1776. 14 Bai D,Sun H,Wang X,et al.MiR-150 inhibits cell growth in vitro and in vivo by restraining the RAB11A/WNT/β-Catenin pathway in thyroid cancer.[J].Med Sci Monit,2017,23:4885-4894. 15 Wang W H,Chen J,Zhao F,et al.MiR-150-5p suppresses colorectal cancer cell migration and invasion through targeting MUC4.[J].Asian Pac J Cancer Prev,2014,15(15):6369-6273. 16 Sun W,Zhang Z,Wang J,et al.MicroRNA-150 supresses cell proliferation and metastasis in hepaocellular carcinoma by inhibiting the GAB1-ERX axis.[J].Oncotarget,2016,7(10):11595-11608. 17 Cao M,Hou D,Liang H,et al.miR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1.[J].Eur J Cancer,2014,50(5):1013-1024. 18 Li J,Hu L,Tian C,at al.microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4[J].BMC Mol Biol,2015,16:24. 19 Wuerkenbieke D,Wang J,Li Y.miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT actination[J].Arch Gynecol Obstet,2015,292(5):1109-1116. |